immunotherapy — grants

Sort

48,018 grants matching “immunotherapy”

Understanding Pancreatic Cancer Immune Microenvironment and Treatment Response through Integrating in vivo Imaging with Immunophenotyping

$649,473

Jun Yan · University Of Louisville · R01 · FY2025 · CA

Ultrasensitive kinase biosensors for multiplex imaging of coordinated spatiotemporal signaling in cancer-immune interactions

$649,143

Jin Zhang · University Of California, San Diego · R01 · FY2022 · CA

Ultrasensitive kinase biosensors for multiplex imaging of coordinated spatiotemporal signaling in cancer-immune interactions

$649,143

Jin Zhang · University Of California, San Diego · R01 · FY2025 · CA

Macrophage-targeting Nanoplatforms as Immunotherapy against Pulmonary Infections

$649,115

Michael J Sailor · University Of California, San Diego · R01 · FY2025 · AI

High throughput nanoplasmonic exosome testing (NEXT) of immunotherapies in bladder cancer

$649,094

Cesar M Castro · Massachusetts General Hospital · R01 · FY2022 · CA

Immune correlates of acute HBV recovery with and without HIV

$649,053

Chloe L Thio · Johns Hopkins University · R01 · FY2017 · AI

Focused Ultrasound Regimens that Synergize with Melanoma Immunotherapy

$648,963

Richard J Price · University Of Virginia · R01 · FY2021 · EB

Advancing treatment outcomes in malignant glioma by integrating immunotherapy and standard of care using genetically engineered mice that recapitulate molecular feature of human glioma

$648,944

Alain Charest · Beth Israel Deaconess Medical Center · R01 · FY2021 · CA

Advancing treatment outcomes in malignant glioma by integrating immunotherapy and standard of care using genetically engineered mice that recapitulate molecular feature of human glioma

$648,944

Alain Charest · Beth Israel Deaconess Medical Center · R01 · FY2020 · CA

Transfer of vaccine-induced immunity from immunocompetent stem cell donor as antiviral immunotherapy to protect high-risk transplant recipients from cytomegalovirus reactivation

$648,910

Don J Diamond · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA

Stomal Senescence Regulator of Tumor Immunity and Progression

$648,846

David G Denardo · Washington University · R01 · FY2024 · CA

Anti-tumor and autoimmunity signatures in Down syndrome

$648,776

Jane Hoyt Buckner · Benaroya Research Inst At Virginia Mason · R01 · FY2023 · CA

Vaccine and Drug Combination Therapy for Human Cancers

$648,692

James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

Vaccine and radiation for the therapy of human cancers

$648,692

James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

Targeting tumoral Lactobacillus iners to improve outcomes in cervical cancers

$648,677

Lauren Elizabeth Colbert · University Of Tx Md Anderson Can Ctr · R37 · FY2025 · CA

Single Cell Analysis of the Infiltrative Margins of Glioblastoma and Post Treatment Recurrence

$648,602

Jeffrey N Bruce · Columbia University Health Sciences · R01 · FY2025 · NS

Targeting T cell dysfunction in glioblastoma: A proof-of-concept Phase 0/I trial of anti-TIGIT antibody AB154 in combination with anti-PD1 antibody AB122

$648,555

David A. Hafler · Yale University · R01 · FY2024 · CA

COMBINATIONAL TARGETING OF PROSTATE CARCINOMA CELLS AND TUMORS ASSOCIATED PERICYTES WITH ANTIBODY BASED IMMUNOTHERAPY AND METRONOMIC CHEMOTHERAPY

$648,552

University Of Pittsburgh - Of The Commonwealth System Of Higher Education · · FY2008 · Department of Defense

Understanding Pancreatic Cancer Immune Microenvironment and Treatment Response through Integrating in vivo Imaging with Immunophenotyping

Heteropolymer System to Treat Vaccinia Complications

Functional Analysis of MicroRNAs and Target Genes in Immune Tolerance

Functional Analysis of MicroRNAs and Target Genes in Immune Tolerance

Functional Analysis of MicroRNAs and Target Genes in Immune Tolerance

Development of a PET Tracer Selective for Cerebral Amyloid Angiopathy

Imaging Acidosis and Immune Therapy in PDAC

Research Training in Academic Medical Oncology

Ultrasensitive kinase biosensors for multiplex imaging of coordinated spatiotemporal signaling in cancer-immune interactions

Ultrasensitive kinase biosensors for multiplex imaging of coordinated spatiotemporal signaling in cancer-immune interactions

Macrophage-targeting Nanoplatforms as Immunotherapy against Pulmonary Infections

High throughput nanoplasmonic exosome testing (NEXT) of immunotherapies in bladder cancer

Immune correlates of acute HBV recovery with and without HIV

Focused Ultrasound Regimens that Synergize with Melanoma Immunotherapy

Advancing treatment outcomes in malignant glioma by integrating immunotherapy and standard of care using genetically engineered mice that recapitulate molecular feature of human glioma

Advancing treatment outcomes in malignant glioma by integrating immunotherapy and standard of care using genetically engineered mice that recapitulate molecular feature of human glioma

Transfer of vaccine-induced immunity from immunocompetent stem cell donor as antiviral immunotherapy to protect high-risk transplant recipients from cytomegalovirus reactivation

Stomal Senescence Regulator of Tumor Immunity and Progression

Anti-tumor and autoimmunity signatures in Down syndrome

Vaccine and Drug Combination Therapy for Human Cancers

Vaccine and radiation for the therapy of human cancers

Targeting tumoral Lactobacillus iners to improve outcomes in cervical cancers

Single Cell Analysis of the Infiltrative Margins of Glioblastoma and Post Treatment Recurrence

Targeting T cell dysfunction in glioblastoma: A proof-of-concept Phase 0/I trial of anti-TIGIT antibody AB154 in combination with anti-PD1 antibody AB122

COMBINATIONAL TARGETING OF PROSTATE CARCINOMA CELLS AND TUMORS ASSOCIATED PERICYTES WITH ANTIBODY BASED IMMUNOTHERAPY AND METRONOMIC CHEMOTHERAPY